Britannia Pharmaceuticals Limited

specialises in developing products for diseases with orphan indications.

Contact Details: United Kingdom Tel: Fax: Email: WWW: www.britannia-pharm.co.uk/

Loading...

Recent Publications by Britannia Pharmaceuticals Limited:
Lofexidine in opiate withdrawal: a safety and usage survey. A retrospective, observational survey, conducted under the remit of the...	26th November, 2008	Britannia Pharmaceuticals Limited, Redhill, Surrey, UK.	Pharmacoepidemiol Drug Saf. 2000 Jan;9(1):43-7. DOI Direct Link

Britannia Pharmaceuticals Limited Clinical Trials:
Apomorphine Nasal Powder in the Treatment of Parkinson's Disease "Off" Periods.

Britannia Pharmaceuticals Limited Patents:
US Patent No.	Title
7473416	Medicaments for asthma treatment
7273604	Anti-asthmatic combinations comprising surface active phospholipids
6824761	Anti-asthmatic combinations comprising surface active phospholipids
6719960	Use of phospholipids for the manufacture of a medicament for the prevention of adhesions
6482391	Medicaments for asthma treatment
→View more Britannia Pharmaceuticals Limited patents.

Contact BioPortfolio for a quote for a customised Excel verision of BioCorporate or BioEmail databases.

This page has been viewed 172 times since April 2007, the link to the organisation's website has been followed 75 times

This site uses Thumbshots previews, resources from the NCBI applied. Maps are centred on zip/postcodes and should not be relied upon for exact building locations. Some information on this page has been collected automatically and may not have been verified.
BioPortfolio search results for Britannia Pharmaceuticals Limited